The PR status is typically determined through a laboratory test called an immunohistochemistry (IHC) assay. This test uses antibodies to detect the presence of progesterone receptors in a sample of the tumor tissue. The result is usually reported as a percentage, indicating the proportion of cells that tested positive for progesterone receptors.
